The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications (Q40707686)

22 September 2017

title

The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications (English)

1 reference

22 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Aníbal Silva

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

Verónica Prado

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

Javier Fernández

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

publication date

14 August 2012

1 reference

22 September 2017

published in

Hepatology international

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

72-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

Management of bacterial infections in cirrhosis.

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Severe sepsis in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Bacterial translocation (BT) in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Extended-spectrum beta-lactamase-producing organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Metallo-β-lactamases: a last frontier for β-lactams?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Coagulation disorders in patients with cirrhosis and severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12072-012-9396-X

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

21 January 2018

1 reference

12 December 2020

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study

1 reference

12 December 2020

Management of adult patients with ascites due to cirrhosis: an update

1 reference

12 December 2020

Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge

1 reference

12 December 2020

Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications

1 reference

12 December 2020

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

1 reference

12 December 2020

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis

1 reference

12 December 2020

Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective study

1 reference

12 December 2020

Epidemiology of Severe Hospital‐Acquired Infections in Patients with Liver Cirrhosis: Effect of Long‐Term Administration of Norfloxacin

1 reference

12 December 2020

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

1 reference

12 December 2020

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

1 reference

12 December 2020

Bacterial infection in cirrhosis, with and without hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S12072-012-9396-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201623 AND SRC:MED&resulttype=core&format=json

14 June 2020

1 reference